[1]
“Association of Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 With Endothelial Dysfunction, Cardiovascular Disease Risk Factors and thrombotic events in Children With End-stage Renal Disease”, IJKD, vol. 12, no. 3, pp. 169–177, Jun. 2018, Accessed: Dec. 04, 2024. [Online]. Available: https://ijkd.org/index.php/ijkd/article/view/3603